Follow Us
© 2026 Arizent. All rights reserved.
Zack Pace is senior vice president, benefits consulting at CBIZ, Inc.
For reprint and licensing requests for this article, click here.
Treating sentiment as a scored, auditable data point will turn subjective impressions into the kind of objective evidence an executive committee can act on.
With health benefit costs expected to rise 8.2% in 2027, employers are looking for ways to control spending without simply shifting more costs to workers.
Collaboration between employers, brokers and third-party administrators will be essential to developing customized, cost-effective and employee-friendly solutions.
As costs to treat serious conditions surge, employers must plan how to absorb budget-altering expenses ahead of time.
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
